KDM3B
KDM3B (also known as Lysine Demethylase 3B) is a protein that in humans is encoded by the KDM3B gene. This protein is a member of the Jumonji domain-containing protein family and functions as a histone demethylase, specifically demethylating histone H3 at lysine 9 (H3K9).
Function[edit]
KDM3B is a histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone modification. KDM3B plays a key role in gene expression, cell cycle regulation, and DNA damage response. It is also involved in the embryonic development and is essential for cell differentiation.
Clinical Significance[edit]
Mutations in the KDM3B gene have been associated with various diseases, including cancer. In particular, overexpression of KDM3B has been observed in several types of cancer, including breast cancer, prostate cancer, and lung cancer. This overexpression is thought to contribute to cancer progression by promoting cell proliferation and inhibiting cell differentiation.
Research[edit]
Research into KDM3B is ongoing, with studies focusing on its role in cancer progression and potential as a therapeutic target. In addition, research is being conducted to better understand the role of KDM3B in embryonic development and cell differentiation.
See Also[edit]
- Histone demethylase
- Jumonji domain-containing protein
- Histone modification
- Gene expression
- Cell cycle
- DNA damage
- Embryonic development
- Cell differentiation
- Cancer
References[edit]
| Genes on human chromosome 5 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This human genetics related article is a stub.
|
| Histone-modifying enzymes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This Histone-modifying enzymes related article is a stub.
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian